Brinker Capital’s GSK GSK Stock Holding History

Brinker Capital’s Portfolio GSK Stock Details GSK Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q2	$1.09M	Buy	21,233 +1,223	+6%	+$62.7K	0.03%	480
2020 Q1	$951K	Buy	20,010 +1,861	+10%	+$99.3K	0.04%	440
2019 Q4	$1.07M	Buy	18,149 +2,139	+13%	+$119K	0.03%	484
2019 Q3	$856K	Buy	16,010 +1,229	+8%	+$63.2K	0.03%	541
2019 Q2	$742K	Sell	14,781 -29	-0.2%	-$1.46K	0.03%	578
2019 Q1	$777K	Sell	14,810 -1,628	-10%	-$81.4K	0.03%	546
2018 Q4	$788K	Sell	16,438 -3,343	-17%	-$165K	0.03%	463
2018 Q3	$997K	Sell	19,781 -870	-4%	-$44.2K	0.04%	497
2018 Q2	$1.04M	Sell	20,651 -334	-2%	-$16.8K	0.04%	467
2018 Q1	$1.03M	Buy	20,985 +4,702	+29%	+$219K	0.04%	457
2017 Q4	$724K	Sell	16,283 -417	-2%	-$19.3K	0.03%	558
2017 Q3	$850K	Buy	16,700 +6,718	+67%	+$341K	0.04%	464
2017 Q2	$540K	Buy	+9,982	New	+$532K	0.03%	505

Other funds holding GSK

Dodge & Cox San Francisco, California $191B AUM 17.5% 1-Year Est. Return

Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

Royal Bank of Canada Toronto, Ontario, Canada $672B AUM 33.48% 1-Year Est. Return

Fisher Asset Management Camas, Washington $336B AUM 34.66% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Hotchkis & Wiley Capital Management Los Angeles, California $34.3B AUM 22.63% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

Brinker Capital's GSK Position: Q2 2020 in Review

Brinker Capital increased its GSK (GSK) stake by 6.1% in Q2 2020, buying an estimated $62.7K and bringing the position to 21,233 shares worth $1.09M. The position accounts for 0.03% of the portfolio, ranked #480.

Brinker Capital first reported a position in GSK in Q2 2017 and has held it in 13 quarters since. 841 funds tracked by Wall St. Rank hold GSK as of Q2 2020.

Brinker Capital held 21,233 shares of GSK worth $1.09M as of Q2 2020.
Brinker Capital bought 1,223 GSK shares in Q2 2020, an estimated $62.7K.
GSK made up 0.03% of Brinker Capital's portfolio in Q2 2020, its #480 holding.
Brinker Capital first reported a position in GSK in Q2 2017 and has held it in 13 quarters since.
841 funds tracked by Wall St. Rank held GSK as of Q2 2020.

Based on Brinker Capital's 13F filing for Q2 2020, filed 30 Jul 2020.